P-ISSN 1176-5178
E-ISSN 1179-3597
Vol. 0, Issue 32, 2021April 22, 2021 NZST
Eosinophilia as a predictor of response to checkpoint inhibition in patients with metastatic melanoma.
Eosinophilia as a predictor of response to checkpoint inhibition in patients with metastatic melanoma.
Bridgman, Tim. 2021. “Eosinophilia as a Predictor of Response to Checkpoint Inhibition in Patients with Metastatic Melanoma.” New Zealand Medical Student Journal 0 (32): 22–24. https://doi.org/10.57129/AEYK1627.